June 2020

Welcome to the June 2020 issue of BioPharma Dealmakers, the biggest issue of the year; more companies looking for partnerships focusing on infectious diseases, cell& gene therapy and more. Read the full here.

About this edition

Our June super-size edition includes companies and editorial features focused upon infectious diseases including vaccines, regenerative medicine and biopharma dealmaking. 

Editorial features in-depth - 

  • Next-generation therapeutics sustain momentum  
  • Partnering for a pandemic
  • Dealmaking in 2020: navigating a new landscape